Prelude Therapeutics Inc Annual Return On Assets in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Prelude Therapeutics Inc quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
  • Prelude Therapeutics Inc Return On Assets for the quarter ending September 30, 2024 was -55.6 %, a 13.4% decline year-over-year.
  • Prelude Therapeutics Inc annual Return On Assets for 2023 was -48 %, a 4.23% decline from 2022.
  • Prelude Therapeutics Inc annual Return On Assets for 2022 was -46.1 %, a 39.8% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -48 -1.95 -4.23% Jan 1, 2023 Dec 31, 2023
2022 -46.1 -13.1 -39.8% Jan 1, 2022 Dec 31, 2022
2021 -33 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.